Display Settings:

Format

Send to:

Choose Destination
We are sorry, but NCBI web applications do not support your browser and may not function properly. More information
    Science. 2010 Feb 26;327(5969):1132-5. doi: 10.1126/science.1183748. Epub 2010 Jan 28.

    Generating a prion with bacterially expressed recombinant prion protein.

    Source

    Department of Molecular and Cellular Biochemistry, Ohio State University, Columbus, OH 43210, USA.

    Abstract

    The prion hypothesis posits that a misfolded form of prion protein (PrP) is responsible for the infectivity of prion disease. Using recombinant murine PrP purified from Escherichia coli, we created a recombinant prion with the attributes of the pathogenic PrP isoform: aggregated, protease-resistant, and self-perpetuating. After intracerebral injection of the recombinant prion, wild-type mice developed neurological signs in approximately 130 days and reached the terminal stage of disease in approximately 150 days. Characterization of diseased mice revealed classic neuropathology of prion disease, the presence of protease-resistant PrP, and the capability of serially transmitting the disease; these findings confirmed that the mice succumbed to prion disease. Thus, as postulated by the prion hypothesis, the infectivity in mammalian prion disease results from an altered conformation of PrP.

    Comment in

    PMID:
    20110469
    [PubMed - indexed for MEDLINE]
    PMCID:
    PMC2893558
    Free PMC Article

    Images from this publication.See all images (3)Free text

    Fig. 1
    Fig. 2
    Fig. 3

      Supplemental Content

      Icon for HighWire Icon for PubMed Central

      Save items

      Recent activity

      Your browsing activity is empty.

      Activity recording is turned off.

      Turn recording back on

      See more...
      Write to the Help Desk